{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:12:36Z","timestamp":1780402356755,"version":"3.54.1"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["CL\/PRI\/C\/4"],"award-info":[{"award-number":["CL\/PRI\/C\/4"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.prp.2025.155815","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:31:55Z","timestamp":1736425915000},"page":"155815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Non-coding RNAs in urinary bladder cancer microenvironment: Diagnostic, therapeutic, and prognostic perspective"],"prefix":"10.1016","volume":"266","author":[{"given":"Enas A.","family":"El Saftawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma Emad","family":"Aboulhoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Ali","family":"AbdElkhalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwah Samir","family":"AlHariry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155815_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102416","article-title":"Comparison of tissue biomarkers between non-schistosoma and schistosoma-associated urothelial carcinoma","author":"AlHariry","year":"2024","journal-title":"Tissue Cell"},{"issue":"8","key":"10.1016\/j.prp.2025.155815_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/biom10081159","article-title":"Role of microRNA\/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancer","volume":"10","author":"Ashrafizadeh","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/carcin\/bgv024","article-title":"Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment","volume":"36","author":"Avgeris","year":"2015","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.prp.2025.155815_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/carcin\/bgz045","article-title":"Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer","volume":"40","author":"Avgeris","year":"2019","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.prp.2025.155815_bib5","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.18632\/aging.101520","article-title":"Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p\/RAB27A axis","volume":"10","author":"Bi","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.prp.2025.155815_bib6","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.7150\/jca.38880","article-title":"Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors","volume":"11","author":"Borgna","year":"2020","journal-title":"J. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2025.155815_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/cancers11101551","article-title":"MicroRNAs which can prognosticate aggressiveness of bladder cancer","volume":"11","author":"Borkowska","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.155815_bib8","first-page":"694","article-title":"Clinical value of microRNA-19a-3p and microRNA-99a-5p in bladder cancer","volume":"19","author":"Borkowska","year":"2020"},{"key":"10.1016\/j.prp.2025.155815_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2147\/IJN.S72904","article-title":"Clinical and pathological implications of mirna in bladder cancer","volume":"10","author":"Braicu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2025.155815_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01393-7","article-title":"Small nucleolar RNAs signature (SNORS) identified clinical outcome and prognosis of bladder cancer (BLCA)","volume":"20","author":"Cao","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-017-0006-x","article-title":"LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer","volume":"25","author":"Cao","year":"2018","journal-title":"Cancer gene Ther."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymthe.2018.12.015","article-title":"DANCR promotes metastasis and proliferation in bladder cancer cells by enhancing IL-11-STAT3 signaling and CCND1 expression","volume":"27","author":"Chen","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.prp.2025.155815_bib13","first-page":"1","article-title":"Molecular mechanism of long non-coding RNA SNHG12 regulating bladder cancer cell activities","author":"Chen","year":"2023","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.prp.2025.155815_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13577-020-00343-9","article-title":"SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition","volume":"33","author":"Chen","year":"2020","journal-title":"Hum. Cell"},{"issue":"15","key":"10.1016\/j.prp.2025.155815_bib15","article-title":"MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2","volume":"22","author":"Chen","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3892\/ijmm.2015.2302","article-title":"miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2","volume":"36","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib17","first-page":"1476","article-title":"MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4","volume":"17","author":"Chen","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.prp.2025.155815_bib18","first-page":"4193","article-title":"Expression of miR-182 and Foxo3a in patients with bladder cancer correlate with prognosis","volume":"12","author":"Chen","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2025.155815_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3892\/or.2020.7910","article-title":"MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing","volume":"45","author":"Chou","year":"2021","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.canlet.2014.10.004","article-title":"Identification of novel piRNAs in bladder cancer","volume":"356","author":"Chu","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jcp.28958","article-title":"Interactive functions of micrornas in the miR-23a-27a-24-2 cluster and the potential for targeted therapy in cancer","volume":"235","author":"Cui","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2025.155815_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02114-4","article-title":"Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT\/STAT3\/NF-kB signaling","volume":"21","author":"Dai","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2025.155815_bib23","article-title":"Heterogeneity of modulatory immune microenvironment in bladder cancer","author":"El Saftawy","year":"2024","journal-title":"Tissue Cell"},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0394632015584733","article-title":"Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment","volume":"28","author":"El-Aal","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"7","key":"10.1016\/j.prp.2025.155815_bib25","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/febs.12737","article-title":"Long non-coding RNA UCA 1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling","volume":"281","author":"Fan","year":"2014","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12935-023-02868-z","article-title":"MicroRNA-122 in human cancers: from mechanistic to clinical perspectives","volume":"23","author":"Faramin Lashkarian","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib27","doi-asserted-by":"crossref","first-page":"18844","DOI":"10.1038\/s41598-020-74807-1","article-title":"Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt","volume":"10","author":"Gaber","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.155815_bib28","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.2147\/OTT.S137433","article-title":"Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study","author":"Gao","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2025.155815_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-019-1102-6","article-title":"Long non-codingRNA ZEB1-AS1 regulates miR-200b\/FSCN1 signaling and enhances migration and invasion induced by TGF-b1 in bladder cancer cells","volume":"38","author":"Gao","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v8.i5.83","article-title":"WNT\/\u03b2-catenin signaling in urothelial carcinoma of bladder","volume":"8","author":"Garg","year":"2019","journal-title":"World J. Nephrol."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2741\/e853","article-title":"Epithelial-to-mesenchymal transition: event and core associates in bladder cancer","volume":"11","author":"Garg","year":"2019","journal-title":"Front. Biosci. -Elite"},{"key":"10.1016\/j.prp.2025.155815_bib32","first-page":"41","article-title":"The evolving understanding of microRNA in bladder cancer","volume":"32","author":"Guancial","year":"2014"},{"key":"10.1016\/j.prp.2025.155815_bib33","article-title":"MicroRNA expression signatures of bladder cancer revealed by deep sequencing","volume":"6","author":"Han","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2019.09.029","article-title":"MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D","volume":"519","author":"Hou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.prp.2025.155815_bib35","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3892\/or.2016.4940","article-title":"). miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion","volume":"36","author":"Huang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.prp.2025.155815_bib36","doi-asserted-by":"crossref","first-page":"15177","DOI":"10.3390\/ijms232315177","article-title":"miR-221-5p and miR-186-5p are the critical bladder cancer derived exosomal miRNAs in natural killer cell dysfunction","volume":"23","author":"Huyan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-022-04791-z","article-title":"Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion","volume":"13","author":"Hwang","year":"2022","journal-title":"Cell death Dis."},{"issue":"17","key":"10.1016\/j.prp.2025.155815_bib38","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.febslet.2014.06.058","article-title":"Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer","volume":"588","author":"Inoguchi","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2025.155815_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084311","article-title":"The microRNA expression signature of bladder cancer by deep sequencing: The functional significance of the miR-195\/497 cluster","volume":"9","author":"Itesako","year":"2014","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.prp.2025.155815_bib40","first-page":"7159","article-title":"Epigenetic biomarkers as a new diagnostic tool in bladder cancer\u2014from early detection to prognosis. journal of clinical medicine","volume":"13","author":"Jaszek","year":"2024"},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/1535-7163.MCT-16-0631","article-title":"Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145","volume":"16","author":"Jiang","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib42","first-page":"5167829","article-title":"MiR-30a: a novel biomarker and potential therapeutic target for cancer","volume":"2018","author":"Jiang","year":"2018","journal-title":"J. Oncol."},{"issue":"35","key":"10.1016\/j.prp.2025.155815_bib43","doi-asserted-by":"crossref","first-page":"56540","DOI":"10.18632\/oncotarget.10645","article-title":"XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63\u03b1 protein translation and promoting transformation of bladder epithelial cells","volume":"7","author":"Jin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155815_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.973585","article-title":"A review on the importance of miRNA-135 in human diseases","volume":"13","author":"Kadkhoda","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2025.155815_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105892","article-title":"Evolution of artificial intelligence as a modern technology in advanced cancer therapy","author":"Khan","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.prp.2025.155815_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105770","article-title":". Recent progress in Zein nanoparticles: a promising approach for advancing Cancer therapy","author":"Khan","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"25","key":"10.1016\/j.prp.2025.155815_bib47","first-page":"2065","volume":"19","author":"Khan","year":"2024","journal-title":"Gall. Acid. loaded self-nano \u00c9muls. hydrogel-Based Drug Deliv. Syst. onychomycosis. Nanomed."},{"key":"10.1016\/j.prp.2025.155815_bib48","article-title":"Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives","author":"Khan","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.prp.2025.155815_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.965231","article-title":"The role of miR-200 family in the regulation of hallmarks of cancer","volume":"12","author":"Klicka","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2025.155815_bib50","article-title":"miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells","author":"Lei","year":"2015","journal-title":"PLoS One, 10(2)"},{"issue":"6","key":"10.1016\/j.prp.2025.155815_bib51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000523853","article-title":"A panel of three serum microRNAs as a potential diagnostic biomarker for urothelial carcinoma","volume":"45","author":"Li","year":"2022","journal-title":"Oncol. Res. Treat."},{"issue":"21","key":"10.1016\/j.prp.2025.155815_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00273-18","article-title":"Decreased c-Myc mRNA stability via the microRNA 141-3p\/AUF1 axis is crucial for p63\u03b1 inhibition of cyclin D1 gene transcription and bladder cancer cell tumorigenicity","volume":"38","author":"Li","year":"2018","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40291-019-00410-4","article-title":"MicroRNAs: key players in bladder cancer","volume":"23","author":"Li","year":"2019","journal-title":"Mol. Diagn. Ther."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ncrna.2022.12.002","article-title":"lncRNA-mediated ceRNA network in bladder cancer","volume":"8","author":"Li","year":"2023","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.prp.2025.155815_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"10","key":"10.1016\/j.prp.2025.155815_bib56","first-page":"7196","article-title":"Long noncoding RNA GHET1 promotes the development of bladder cancer","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2025.155815_bib57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/carcin\/bgs383","article-title":"MiR-124 targets Slug to regulate epithelial-mesenchymaltransition and metastasis of breast cancer","volume":"34","author":"Liang","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib58","first-page":"151","article-title":"Bladder cancer cell-secreted exosomal miR-21 activates the PI3K\/AKT pathway in macrophages to promote cancer progression","volume":"56","author":"Lin","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2025.155815_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-015-0028-3","article-title":"miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13577-019-00285-x","article-title":"MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K\/AKT pathway","volume":"33","author":"Liu","year":"2020","journal-title":"Hum. Cell"},{"issue":"12","key":"10.1016\/j.prp.2025.155815_bib61","doi-asserted-by":"crossref","first-page":"19330","DOI":"10.1002\/jcb.27318","article-title":"MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival","volume":"120","author":"Liu","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.prp.2025.155815_bib62","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.17219\/acem\/159475","article-title":"LncRNA SNHG12 promotes proliferation and migration of hepatic progenitor cells via the Wnt\/\u03b2-catenin pathway","volume":"32","author":"Liu","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.prp.2025.155815_bib63","first-page":"635","article-title":"MicroRNA-221 Silencing Predisposed Human Bladder Cancer Cells to Undergo Apoptosis Induced by TRAIL","volume":"28","author":"Lu","year":"2010"},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib64","first-page":"32","article-title":"Evaluation of miR-141, miR-200c, miR-30b expression and clinicopathological features of bladder cancer","volume":"4","author":"Mahdavinezhad","year":"2015","journal-title":"Int. J. Mol. Cell. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.239","article-title":"Effects of microRNA-135a on the epithelial\u2013mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3\u03b2 through the Wnt\/\u03b2-catenin signaling pathway","volume":"50","author":"Mao","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.239","article-title":"Effects of microRNA-135a on the epithelial\u2013mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3\u03b2 through the Wnt\/\u03b2-catenin signaling pathway","volume":"50","author":"Mao","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib67","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/cancers16020434","article-title":"Relevance of HOTAIR rs920778 and rs12826786 genetic variants in bladder cancer risk and survival","volume":"16","author":"Martins","year":"2024","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib68","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1002\/jcb.28045","article-title":"circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma","volume":"120","author":"Matboli","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"19","key":"10.1016\/j.prp.2025.155815_bib69","doi-asserted-by":"crossref","first-page":"28460","DOI":"10.18632\/oncotarget.8668","article-title":"Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): inhibition of bladder cancer cell aggressiveness","volume":"7","author":"Matsushita","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prp.2025.155815_bib70","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2025.155815_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2018.12.028","article-title":"MicroRNA biomarkers for patients with muscle-invasive bladder cancer undergoing selective bladder-sparing trimodality treatment","volume":"104","author":"Meng","year":"2019","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.prp.2025.155815_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijbiomac.2017.07.184","article-title":"Down-regulation of microRNA-224-inhibites growth and epithelial-to-mesenchymal transition phenotype-via modulating SUFU expression in bladder cancer cells","volume":"106","author":"Miao","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib73","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/iju.IJU_4_17","article-title":"MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer","volume":"33","author":"Mitash","year":"2017","journal-title":"Indian J. Urol."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0970-1591.203412","article-title":"Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance","volume":"33","author":"Mitash","year":"2017","journal-title":"Indian J. Urol."},{"issue":"3","key":"10.1016\/j.prp.2025.155815_bib75","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.2016.179","article-title":"Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer","volume":"115","author":"Miyamoto","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12935-014-0119-3","article-title":"The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability","volume":"14","author":"Morais","year":"2014","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib77","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2018_180512N312","article-title":"MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4","volume":"66","author":"Na","year":"2019","journal-title":"Neoplasma"},{"issue":"11","key":"10.1016\/j.prp.2025.155815_bib78","first-page":"4892","article-title":"MiR-4295 promotes cell growth in bladder cancer by targeting BTG1","volume":"8","author":"Nan","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.prp.2025.155815_bib79","article-title":"Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia","volume":"226","author":"Nashwa","year":"2021","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41576-018-0073-3","article-title":"PIWI-interacting RNAs: small RNAs with big functions","volume":"20","author":"Ozata","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.prp.2025.155815_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-020-01435-0","article-title":"MicroRNAs and target molecules in bladder cancer","volume":"37","author":"Parizi","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2025.155815_bib82","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.prp.2025.155815_bib83","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/mc.23028","article-title":"The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p\/metalloproteinases 3 axis","volume":"58","author":"Peng","year":"2019","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12913","article-title":"Essential functions of miR-125b in cancer","volume":"54","author":"Peng","year":"2021","journal-title":"Cell Prolif."},{"issue":"11","key":"10.1016\/j.prp.2025.155815_bib85","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.27949","article-title":"microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer","volume":"132","author":"Pignot","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2025.155815_bib86","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/ijms18071514","article-title":"Understanding the role of non-coding RNAs in bladder cancer: from dark matter to valuable therapeutic targets","volume":"18","author":"Pop-Bica","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155815_bib87","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/CMAR.S223172","article-title":"LncRNA NCK1-AS1 promotes cancer cell proliferation and increase cell stemness in urinary bladder cancer patients by downregulating miR-143","author":"Qiao","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2025.155815_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.12.028","article-title":"HOTAIR LncRNA: a novel oncogenic propellant in human cancer","volume":"503","author":"Rajagopal","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"48","key":"10.1016\/j.prp.2025.155815_bib89","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1038\/s41388-021-02033-8","article-title":"Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA\/RhoC mRNA and impairing bladder cancer invasion","volume":"40","author":"Ren","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib90","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41598-017-00327-0","article-title":"Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer","volume":"7","author":"Seitz","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41598-017-00327-0","article-title":"Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer","volume":"7","author":"Seitz","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2025.155815_bib92","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1134\/S0006297921070014","article-title":"MicroRNAs in cancer: from gene expression regulation to the metastatic niche reprogramming","volume":"86","author":"Semina","year":"2021","journal-title":"Biochem. (Mosc. )"},{"key":"10.1016\/j.prp.2025.155815_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02063-y","article-title":"LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146","volume":"21","author":"Shan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2025.155815_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109248","article-title":"Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1","volume":"121","author":"Shan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib95","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.prp.2018.11.018","article-title":"The deregulation of miR-133b is associated with poor prognosis in bladder cancer","volume":"215","author":"Shi","year":"2019","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2025.155815_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109932","article-title":"LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28\/TGF-\u03b2\/Smad pathway","volume":"81","author":"Shi","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prp.2025.155815_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109932","article-title":"LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28\/TGF-\u03b2\/Smad pathway","volume":"81","author":"Shi","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prp.2025.155815_bib98","doi-asserted-by":"crossref","first-page":"6617118","DOI":"10.1155\/2021\/6617118","article-title":"In silico analysis of common long noncoding RNAs in schistosoma mansoni and schistosoma haematobium","volume":"2021","author":"Sirekbasan","year":"2021","journal-title":"J. Trop. Med."},{"issue":"11-12","key":"10.1016\/j.prp.2025.155815_bib99","article-title":"Small non-coding RNA within the endogenous spliceosome and alternative splicing regulation","volume":"1862","author":"Sperling","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Gene Regul. Mech."},{"key":"10.1016\/j.prp.2025.155815_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1129-5","article-title":"circRIP2 accelerates bladder cancer progression via miR-1305\/Tgf-\u03b22\/smad3 pathway","volume":"19","author":"Su","year":"2020","journal-title":"Mol. Cancer"},{"issue":"54","key":"10.1016\/j.prp.2025.155815_bib101","doi-asserted-by":"crossref","first-page":"93279","DOI":"10.18632\/oncotarget.21565","article-title":"Inflammatory microenvironment in the initiation and progression of bladder cancer","volume":"8","author":"Sui","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib102","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13577-020-00470-3","article-title":"LncRNA MAFG-AS1 regulates miR-125b-5p\/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells","volume":"34","author":"Tang","year":"2021","journal-title":"Hum. Cell"},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib103","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/ijms25042178","article-title":"The role of miRNAs to detect progression, stratify, and predict relevant clinical outcomes in bladder cancer","volume":"25","author":"Torres-Bustamante","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.prp.2025.155815_bib104","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/ijc.24183","article-title":"MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31","volume":"124","author":"Veerla","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/cancers15041007","article-title":"The diagnostic and therapeutic role of snoRNA and lincRNA in bladder cancer","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.155815_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103032","article-title":"Which type of cancer patients are more susceptible to the SARS-COX-2: evidence from a meta-analysis and bioinformatics analysis","volume":"153","author":"Wang","year":"2020","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"12","key":"10.1016\/j.prp.2025.155815_bib107","doi-asserted-by":"crossref","first-page":"16295","DOI":"10.1007\/s13277-016-5460-9","article-title":"MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3\u03b2 and activating Wnt signaling in bladder cancer cells","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib108","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3892\/ol.2016.5388","article-title":"miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/CBM-182000","article-title":"MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer","volume":"24","author":"Wang","year":"2019","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/096504017X14902261600566","article-title":"MicroRNA-940 targets INPP4A or GSK3\u03b2 and activates the Wnt\/\u03b2-catenin pathway to regulate the malignant behavior of bladder cancer cells","volume":"26","author":"Wang","year":"2018","journal-title":"Oncol. Res."},{"issue":"7","key":"10.1016\/j.prp.2025.155815_bib111","first-page":"3056","article-title":"MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib112","first-page":"1190","article-title":"miRNA-373 promotes urinary bladder cancer cell proliferation, migration and invasion through upregulating epidermal growth factor receptor","volume":"17","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"15","key":"10.1016\/j.prp.2025.155815_bib113","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1111\/jcmm.15480","article-title":"A SNP of miR-146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR-146a signallings","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib114","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.18632\/aging.202247","article-title":"Silencing LINC00482 inhibits tumor-associated inflammation and angiogenesis through down-regulation of MMP-15 via FOXA1 in bladder cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"10.1016\/j.prp.2025.155815_bib115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics\u2014challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.prp.2025.155815_bib116","doi-asserted-by":"crossref","first-page":"26593","DOI":"10.18632\/oncotarget.8557","article-title":"MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155815_bib117","article-title":"Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.155815_bib118","doi-asserted-by":"crossref","first-page":"664","DOI":"10.18632\/oncotarget.13507","article-title":"PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth","volume":"8","author":"Xiang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib119","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1535-7163.MCT-12-0273","article-title":"miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR","volume":"12","author":"Xu","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2025.155815_bib120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ebiom.2019.08.074","article-title":"Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation","volume":"48","author":"Yan","year":"2019","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.prp.2025.155815_bib121","article-title":"MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K\/AKT pathway","volume":"23","author":"Yan","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2025.155815_bib122","doi-asserted-by":"crossref","first-page":"68721","DOI":"10.18632\/oncotarget.19878","article-title":"Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"40","key":"10.1016\/j.prp.2025.155815_bib123","doi-asserted-by":"crossref","first-page":"67663","DOI":"10.18632\/oncotarget.18801","article-title":"MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib124","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4103\/jcrt.jcrt_1014_21","article-title":"Urinary microRNA-10a levels in diagnosis and prognosis of urinary bladder cancer","volume":"19","author":"Zaidi","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.prp.2025.155815_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-1143-7","article-title":"Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2","volume":"19","author":"Zhan","year":"2020","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2025.155815_bib126","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/tox.23331","article-title":"MiR-186-5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A\/B","volume":"36","author":"Zhang","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"3","key":"10.1016\/j.prp.2025.155815_bib127","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41417-019-0085-y","article-title":"The circINTS4\/miR-146b\/CARMA3 axis promotes tumorigenesis in bladder cancer","volume":"27","author":"Zhang","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2025.155815_bib128","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18530","article-title":"Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis","volume":"12","author":"Zhang","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.prp.2025.155815_bib129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.039","article-title":"NF-\u03baB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a\/NF-\u03baB\/Snail signaling in bladder cancer cells","volume":"710","author":"Zhang","year":"2019","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.prp.2025.155815_bib130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41419-018-0986-y","article-title":"MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting \u03b2-catenin and CDK2 and activating p21","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"55","key":"10.1016\/j.prp.2025.155815_bib131","doi-asserted-by":"crossref","first-page":"93969","DOI":"10.18632\/oncotarget.21400","article-title":"Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.prp.2025.155815_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143441","article-title":"MicroRNA-203 is a prognostic indicator in bladder cancer and enhances chemosensitivity to cisplatin via apoptosis by targeting Bcl-w and survivin","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.prp.2025.155815_bib133","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.juro.2016.05.107","article-title":"lncRNA up-regulated in nonmuscle invasive bladder cancer facilitates tumor growth and acts as a negative prognostic factor of recurrence","volume":"196","author":"Zhang","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.155815_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7819-12-241","article-title":"Increased expression of miR-222 is associated with poor prognosis in bladder cancer","volume":"12","author":"Zhang","year":"2014","journal-title":"World J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib135","first-page":"2839","article-title":"Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt\/\u03b2-catenin signalling pathway","volume":"42","author":"Zhao","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.prp.2025.155815_bib136","first-page":"1382","article-title":"MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer","volume":"7","author":"Zhao","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2025.155815_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-32-10","article-title":"microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer","volume":"32","author":"Zhao","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2025.155815_bib138","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12282-019-00989-w","article-title":"MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1","volume":"26","author":"Zhao","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.prp.2025.155815_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0880-3","article-title":"Exosome\u2013transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression","volume":"17","author":"Zheng","year":"2018","journal-title":"Mol. Cancer"},{"issue":"30","key":"10.1016\/j.prp.2025.155815_bib140","doi-asserted-by":"crossref","first-page":"2303473","DOI":"10.1002\/advs.202303473","article-title":"LncRNA BCCE4 genetically enhances the PD-L1\/PD-1 interaction in smoking-related bladder cancer by modulating miR-328-3p-USP18 signaling","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.prp.2025.155815_bib141","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.3892\/ol.2015.3689","article-title":"miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation","volume":"10","author":"Zhou","year":"2015","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2025.155815_bib142","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbrc.2015.10.002","article-title":"Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway","volume":"467","author":"Zhu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.155815_bib143","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.omtn.2019.04.007","article-title":"MicroRNA-146b overexpression promotes human bladder cancer invasion via enhancing ETS2-mediated mmp2 mRNA transcription","volume":"16","author":"Zhu","year":"2019","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.prp.2025.155815_bib144","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.omtn.2019.04.007","article-title":"MicroRNA-146b overexpression promotes human bladder cancer invasion via enhancing ETS2-mediated mmp2 mRNA transcription","volume":"16","author":"Zhu","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.prp.2025.155815_bib145","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","article-title":"Cancer-associated fibroblast\u2013derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance","volume":"83","author":"Zhuang","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2025.155815_bib146","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.7150\/thno.19542","article-title":"TGF\u03b21 promotes gemcitabine resistance through regulating the LncRNA-LET\/NF90\/miR-145 signaling axis in bladder cancer","volume":"7","author":"Zhuang","year":"2017","journal-title":"Theranostics"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:25:59Z","timestamp":1778747159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382500007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":146,"alternative-id":["S034403382500007X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155815","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in urinary bladder cancer microenvironment: Diagnostic, therapeutic, and prognostic perspective","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155815"}}